# FDA Inspection 1317052 - Solaris Pharma Corp - April 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/b9f7b248-5c1f-4449-87fb-53f958ce2070
Source feed: FDA_Inspections

> FDA Inspection 1317052 for Solaris Pharma Corp on April 21, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1317052
- Company Name: Solaris Pharma Corp
- Inspection Date: 2026-04-21
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1283114 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/21c2d32d-4377-4be5-8382-b321a855a9ae)
- [FDA Inspection 1283114 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/a78a33e0-bed5-43f4-8243-b3dddf80fd56)
- [FDA Inspection 1117923 - 2020-01-09](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/84366ff4-2f07-49eb-89c5-e3009928fbd2)

Company: https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248